Jubilant Pharmova Ltd Subsidiary to Acquire 80% Stake in Pierre Fabre SA's R&D Centre in France

Jubilant Biosys Innovative Research Services Pte Ltd, a subsidiary of Jubilant Biosys Limited, a wholly owned subsidiary of Jubilant Pharmova Ltd, has executed the transaction definitive agreements with Pierre Fabre SA and its affiliate entities. The agreement is for Jubilant Biosys Innovative Research Services Pte Limited to acquire 80% equity capital in JASMIN, a new company incorporated by PF in France, with the remaining 20% retained by PF. The French Ministry of Economy and Finance has asserted that the Transaction is not subject to foreign investment control in France. At Closing of the transaction, JASMIN shall acquire PF’s R&D Centre, including R&D Site and R&D activities, at Saint Julien, France. The date and time of occurrence of event is 8.32 p.m. (IST) on Tuesday, January 28, 2025.